Corporate Communications Europe Daiichi Sankyo Europe GmbH Nadine Paschen [email protected] Tel. +49 89 7808 590 Julia Thienel [email protected] Tel. +49 89 7808 140 ...

ANN ARBOR, Mich. and MUNICH, Germany, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ: ESPR) and Daiichi Sankyo Europe GmbH (DSE), the European headquarter organization of ...

Esperion and Daiichi Sankyo Europe entered into the commercialization and licensing agreement in January 2019 in a deal that included $300 million in upfront payments with the potential of ...

Earnings Call Insights: Daiichi Sankyo (OTCPK:DSKYF) Q3 2024 Management View Revenue for Q3 FY2024 increased 16.6% year-on-year to ¥1,367.6 billion, driven by growth in oncology and international ...

Daiichi Sankyo Europe has licensed exclusive commercialisation rights to bempedoic acid in the European Economic Area, Turkey and Switzerland from Esperion and is the full Marketing Authorisation ...

Daiichi Sankyo Europe, DSE Europe have been factories, concerning this DXd-ADC capital investment has been made and we have expanded the production facilities and we would reinforce it.

Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the safety and efficacy of ifinatamab deruxtecan (I-DXd) in individuals with ...

AstraZeneca, which is partnered with Daiichi Sankyo on the drug, has cited Dato-DXd as one of the products that will help it achieve its goal of nearly doubling its revenue to $80 billion by 2030 ...

Masahiro Kato takes over as Managing Director, Oliver Appelhans appointed to Head of the European Specialty Business Unit. Masahiro Kato appointed as Managing Director of Daiichi Sankyo Europe GmbH ...

--Esperion Therapeutics, Inc. and Daiichi Sankyo Europe GmbH, the European headquarter organization of the Japanese pharmaceutical company Daiichi Sankyo Co., Ltd., announced today a $125 million ...

Daiichi Sankyo Europe's Specialty portfolio focuses on cardiovascular care and generated revenues of more than 1bn EUR in the last fiscal year. Oliver Appelhans joined Daiichi Sankyo in 2007 after ...